NasdaqGS:DXCMMedical Equipment
DexCom (DXCM) Margin Expansion To 17.9% Reinforces Bullish Earnings Narratives
DexCom (DXCM) has wrapped up FY 2025 with fourth quarter revenue of US$1.3b and basic EPS of US$0.69, capping a year where trailing twelve month revenue reached US$4.7b and EPS came in at US$2.14. Over the past six reported quarters, the company has seen quarterly revenue move from US$994.2m in Q3 2024 to US$1.3b in Q4 2025, with basic EPS ranging from US$0.27 in Q1 2025 to US$0.73 in Q3 2025. This gives investors a clear view of how the top line and per share earnings have evolved through...